R.PR
REGISTERED-PRINCIPAL REGISTER
02/15/2022
Back to search
Official data from USPTO
CH ONDEMAND FOR CLINICIANS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
42
Latest update
10/21/2022
Trademark type
Combined
Nice classes
9
Filing date
02/28/2020
Registration date
02/15/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/15/2022
Last transaction
10/21/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
04/14/2020
First use in commerce
04/14/2020
Drawing code
3
Owner type
03
Owner location
Buffalo, NY, US
Examiner
KING, LINDA
Law office
M70
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the characters "CH ONDEMAND FOR CLINICIANS" having a stylized quotation mark-like design formed by two curved flags to the left of the characters.
Holders and representatives
Holders
Catholic Health System, Inc.
Representatives
David L. Principe Phillips Lytle LLP
Technical classification
Nice Classes
Class 9
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Downloadable mobile application for use by medical clinicians to electronically manage and process patient data and appointments
Publications
History of USPTO decisions and trademark events.
42 publications found
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
01/11/2022
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
01/10/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/09/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/09/2021
ALIE
ASSIGNED TO LIE
12/09/2021
NREV
NOTICE OF REVIVAL - E-MAILED
12/06/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/06/2021
PETG
PETITION TO REVIVE-GRANTED
12/06/2021
PROA
TEAS PETITION TO REVIVE RECEIVED
12/06/2021
MAB2
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
10/04/2021
ABN2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
10/04/2021
DOCK
ASSIGNED TO EXAMINER
09/30/2021
EEXT
SOU TEAS EXTENSION RECEIVED
08/24/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/15/2021
GNRT
NON-FINAL ACTION E-MAILED
03/15/2021
CNRT
SU - NON-FINAL ACTION - WRITTEN
03/15/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/13/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/12/2021
EX1G
SOU EXTENSION 1 GRANTED
03/12/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/12/2021
IUAF
USE AMENDMENT FILED
02/24/2021
EXT1
SOU EXTENSION 1 FILED
02/24/2021
EEXT
SOU TEAS EXTENSION RECEIVED
02/24/2021
EISU
TEAS STATEMENT OF USE RECEIVED
02/24/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
08/25/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/30/2020
PUBO
PUBLISHED FOR OPPOSITION
06/30/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/10/2020
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
06/10/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/10/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/10/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/10/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/21/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
05/21/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/21/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
05/21/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/21/2020
DOCK
ASSIGNED TO EXAMINER
05/19/2020
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
03/07/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/06/2020
NWAP
NEW APPLICATION ENTERED
03/05/2020
Continuous trademark protection
Get notified about every new filing that threatens CH ONDEMAND FOR CLINICIANS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.